Courtney Oleary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

bluebird bio, Inc (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript

Operator: Good day, and welcome to bluebird bio Fourth Quarter and 2023 Annual Results Conference Call. At this time all participants are in a listen-only mode.

United statesChris krawtschukAndrew obenshainJason gerberryCourtney olearyRaymond jamesDeric josephDanielle brillJack allenGena wangMani forooharTom klimaMorgan stanleyBluebird bio incTop selling energy drink brandsCall transcript march

bluebird bio to Present at the 42nd Annual J P Morgan Healthcare Conference

bluebird bio to Present at the 42nd Annual J P Morgan Healthcare Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Courtney olearyJess rowlandsAndrew obenshainHealthcare conference

bluebird bio, Inc Announces Pricing of $125 Million Public Offering of Common Stock

bluebird bio, Inc Announces Pricing of $125 Million Public Offering of Common Stock
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCourtney olearyJess rowlandsRaymond james associates incGoldman sachs coBroadridge financial solutionsExchange commissionProspectus departmentJp morgan securitiesGoldman sachsIsland avenuePrivate securities litigation reform actAnnual reportQuarterly reportsCurrent reports

Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels

SOMERVILLE, Mass. (BUSINESS WIRE) Dec 10, 2023

United statesJess rowlandsBetibeglogene autotemcelCourtney olearyRichard colvinAmerican society of hematologyExchange commissionAmerican societyAnnual meetingSafety resultsImproved qualityLife measuresPediatric patients with transfusion dependentPost treatment with betibeglogene autotemcelIron burdenPatients with transfusion dependent

Long-term Follow-up Data From bluebird s Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Resolution of Vaso-Occlusive Events | Business

SOMERVILLE, Mass. (BUSINESS WIRE) Dec 9, 2023

United statesJulie kanterRichard colvinCourtney olearyJess rowlandsDivision of hematologyAmerican society of hematologyExchange commissionDrug administrationAmerican societyAnnual meetingAlabama birmingham adult sickle cell clinicMarketing long term follow up studyPrescribing informationPrivate securities litigation reform actAnnual report